Cancer procoagulant (CP) in lung cancer.
Lung cancers (squamous cell carcinoma, microcellular carcinoma, macrocellular carcinoma and adenocarcinoma) show procoagulant activity. It mainly depends on the presence of cancer procoagulant (CP) in lung cancer cells.
Rucińska
M
M
Department of Oncology, Medical Academy of Białystok.
Skrzydlewski
Z
Z
Zaremba
E
E
Furman
M
M
Kasacka
I
I
D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000737:chemistry*; D003546:Cysteine Endopeptidases / Q000032:analysis*; D006801:Humans; D008168:Lung / Q000737:chemistry; D008175:Lung Neoplasms / Q000737:chemistry*; D009363:Neoplasm Proteins / Q000032:analysis*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D003546:Cysteine Endopeptidases; C030910:cancer procoagulant